The first data on international multicenter clinical study RheoSTAT-CP0691 on the efficacy and safety of Rheosorbilact® infusion in therapy of purulent peritonitis. (2022). Perioperaciina Medicina, 5(1), 34-46. https://doi.org/10.31636/prmd.v5i1.5